Âé¶¹´«Ã½Ó³»­

Âé¶¹´«Ã½Ó³»­

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Neuroinfectious Disease Inquiries within the Emerging Infections Network: Prevalence and Characteristics
Infectious Disease
P10 - Poster Session 10 (5:30 PM-6:30 PM)
13-009
N/A
To monitor emerging infectious diseases, the Center for Disease Control (CDC) and the Infectious Disease Society of America (IDSA) established the Emerging Infections Network (EIN), allowing infectious diseases (ID) specialists to post inquiries regarding clinical cases.  Here we describe the frequency and characteristics of inquiries related to neuroinfectious diseases.
We retrospectively reviewed the EIN clinical listserv archives using the search terms: meningitis, encephalitis/encephalopathy, myelitis/myelopathy, and neuropathy. We collected title, date, disease category, inquiry type (diagnostic approach, result interpretation, management decisions, other), clinical details, particular circumstances (i.e. unique patient populations, specific exposures), pathogen, and ultimate diagnosis.

Of the 2344 total inquiries from 2/1997-2/2019, we identified 179 (8%) related to neuroinfectious diseases. The majority of inquiries related to meningitis (51%) and encephalitis (30%). One-hundred-fourteen (64%) related to management, 57 (32%) to diagnostic work-up and 43 (24%) to result interpretation. Six (4%) specifically related to results of meningitis/encephalitis pathogen polymerase chain reaction testing. Many involved specific patient populations (23% immunosuppressed, 17% children) or known exposures (7% with exposure to particular species, 7% had recent surgery/instrumentation, 6% from developing countries, 2% with recent travel abroad). Thirty-two percent of cases pertained bacteria, 23% virus, 15% fungi, 2% parasites; 28% had no pathogen identified. The most common pathogens were Cryptococcus neoformans (9%), herpes simplex virus (8%) and Borrelia burgdorferi (5%). In forty-two (23%) inquiries, patients had neurologic symptoms without a clear infectious etiology; twelve (29%) of these inquiries had non-infectious etiologies on the differential (either in the initial inquiry or responses).

Neuroinfectious diseases represent an important and challenging component of the clinical practice of ID practitioners; many cases may be non-infectious. It is critical for ID specialists to recognize potential non-infectious, neurologic disorders that may present similarly to infectious processes. These complex cases may also benefit from an interdisciplinary approach.
Authors/Disclosures
Elizabeth Matthews, MD
PRESENTER
Dr. Matthews has nothing to disclose.
Luisa A. Diaz-Arias, MD (Luisa Diaz Arias) Dr. Diaz-Arias has nothing to disclose.
No disclosure on file
No disclosure on file
Greer Waldrop, MD (UCSF) Dr. Waldrop has nothing to disclose.
Vivian Yang, MD (New York Presbyterian Columbia) Dr. Yang has nothing to disclose.
Kathryn T. Fong, MD (Swedish Multiple Sclerosis Center) Dr. Fong has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono. Dr. Fong has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Dr. Fong has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. Dr. Fong has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD Serono. Dr. Fong has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for TG Therapeutics.
Arun Venkatesan, MD, PhD (Johns Hopkins Hospital) Dr. Venkatesan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen Pharmaceuticals. The institution of Dr. Venkatesan has received research support from NIH. The institution of Dr. Venkatesan has received research support from U.S. DOD.
Kiran Thakur, MD, FÂé¶¹´«Ã½Ó³»­ (Columbia University College of Physicians and Surgeons) Dr. Thakur has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Delve Bio.